November 19, 2017

ESC: Detecting Fibrosis with MRI to Improve Atrial Fibrillation Catheter Ablation Success

Here is an update on the DECAAF study that Dr. Nassir Marrouche presented at the European Society of Cardiology in Amsterdam today. According to Dr. Marrouche, the amount of fibrosis (scar tissue created in the heart by atrial fibrillation), as measured on pre-ablation MRIs (magnetic resonance imaging), predicts the success of catheter ablations for atrial […]

Dr. Nassir Marrouche on Multicenter Atrial Fibrillation DECAAF Trial Presented at HRS — Video

In the late breaking clinical trials session at Heart Rhythm 2013, Dr. Nassir Marrouche presented results of the multicenter DECAAF trial. Dr. Marrouche talked with us on video about the results presented at HRS, including the role of hypertension (high blood pressure) in the development of atrial fibrosis and the evaluation by MRI of atrial […]

Atrial Fibrosis, Not Afib Type, Linked to Atrial Fibrillation Strokes

Researchers at the Comprehensive Arrhythmia Research and Management Center (CARMA) in Utah have been studying the relationship between atrial fibrillation, atrial fibrosis, and catheter ablation outcomes for many years. Now, they’ve applied their knowledge of quantifying atrial fibrosis to stroke risk assessment and found that the amount of atrial fibrosis, not type of afib, is […]

What Factors Can Predict Atrial Fibrillation Catheter Ablation Success

Doctors are trying to identify the characteristics that predict which patients aren’t likely to be successful with a catheter ablation for their atrial fibrillation. At a session at the recent Heart Rhythm Society annual meeting, some of the factors discussed included left atrial size, left atrial volume, left ventricle dysfunction (improper functioning of the left […]

Dr. Nassir Marrouche Discusses Use of MRI to Personalize Atrial Fibrillation Treatment and Avoid Stroke – Video

In this video interview, Dr. Nassir Marrouche, Executive Director of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System, discusses the findings he recently presented at the Heart Rhythm Society annual meeting in Denver. He discussed the intriguing way they are using MRI (magnetic resonance imaging), to personalize atrial […]

Atrial Fibrillation & the DECAAF trial–StopAfib.org interviews Dr. Nassir Marrouche (Part 2 or 2)

In this video interview, Dr. Nassir Marrouche talked about the exciting research he and his team presented at Heart Rhythm 2010 that allows them to personalize atrial fibrillation (AF) treatment. They do catheter ablations and manage stroke prevention based on the amount of atrial fibrosis and atrial remodeling detected by

Atrial Fibrillation and MRI–StopAfib.org interviews Dr. Nassir Marrouche (Part 1 of 2)

In this video interview, Dr. Nassir Marrouche talked about the exciting research he and his team presented at Heart Rhythm 2010 that allows them to personalize atrial fibrillation (AF) treatment. They do catheter ablations and manage stroke prevention based on the amount of atrial fibrosis and atrial remodeling detected by

Use of MRI to Personalize Atrial Fibrillation Treatment and Avoid Stroke – Presentation by Dr. Nassir Marrouche at HRS

At Heart Rhythm Society 2010, we saw intriguing new research into personalized afib treatment and stroke prevention that was presented by Dr. Nassir Marrouche and Dr. Marcos Daccarett of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System. They have developed a way, using MRI (magnetic resonance imaging), to […]